Literature DB >> 15529850

Application of robotics in general surgery: initial experience.

Ninh T Nguyen1, Marcelo W Hinojosa, David Finley, Melinda Stevens, Mahbod Paya.   

Abstract

Robotic surgery was recently approved for clinical use in general abdominal surgery. The aim of this study was to review our experience with the da Vinci surgical system during laparoscopic general surgical procedures. Eighteen patients underwent robotically assisted laparoscopic abdominal surgery between June 2002 and March 2003. Main outcome measures were operative time, room setup time, robotic arm-positioning and surgical time, blood loss, conversion to laparoscopy, length of stay, and morbidity. The types of robotically assisted laparoscopic procedures were excision of gastric leiomyoma (n = 1), Heller myotomy (n = 1), cholecystectomy (n = 2), gastric banding (n = 2), Nissen fundoplication (n = 4), and gastric bypass (n = 8). The mean room setup time was 63 +/- 14 minutes, and the mean robotic arm-positioning time was 16 +/- 7 minutes. Conversion to laparoscopy occurred in two (11%) of 18 cases because of equipment difficulty (n = 1) and technical difficulty (n = 1). Estimated blood loss was 91 +/- 71 mL. The mean operative time was 156 +/- 42 minutes, and the robotic operative time was 27% of the total operative time. The mean length of hospital stay was 2.2 +/- 1.5 days. There was one postoperative wound infection and one anastomotic stricture. Robotically assisted laparoscopic abdominal surgery is feasible and safe; however, the theoretical advantages of the da Vinci surgical system were not clinically apparent.

Entities:  

Mesh:

Year:  2004        PMID: 15529850

Source DB:  PubMed          Journal:  Am Surg        ISSN: 0003-1348            Impact factor:   0.688


  12 in total

Review 1.  Laparoscopic transcystic duct common bile duct exploration.

Authors:  S Lyass; E H Phillips
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

2.  Robotic surgery in ear nose and throat.

Authors:  Amit Parmar; David G Grant; Peter Loizou
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-06-27       Impact factor: 2.503

3.  Survey of minimally invasive general surgery fellows training in robotic surgery.

Authors:  Abhijit Shaligram; Avishai Meyer; Anton Simorov; Pradeep Pallati; Dmitry Oleynikov
Journal:  J Robot Surg       Date:  2012-05-13

4.  The patterns and costs of the Da Vinci robotic surgery system in a large academic institution.

Authors:  Rhonda Prewitt; Victor Bochkarev; Corrigan L McBride; Sonja Kinney; Dmitry Oleynikov
Journal:  J Robot Surg       Date:  2008-04-02

5.  How does the robot affect outcomes? A retrospective review of open, laparoscopic, and robotic Heller myotomy for achalasia.

Authors:  Abhijit Shaligram; Jayaraj Unnirevi; Anton Simorov; Vishal M Kothari; Dmitry Oleynikov
Journal:  Surg Endosc       Date:  2011-10-25       Impact factor: 4.584

6.  Robotic-assisted paraesophageal hernia repair--a case-control study.

Authors:  Tobias Gehrig; A Mehrabi; L Fischer; H Kenngott; U Hinz; C N Gutt; Beat P Müller-Stich
Journal:  Langenbecks Arch Surg       Date:  2012-07-31       Impact factor: 3.445

7.  Surgical treatment of gastroesophageal reflux disease and upside-down stomach using the Da Vinci robotic system. A prospective study.

Authors:  Jens Hartmann; Christoph A Jacobi; Charalambos Menenakos; Mahmoud Ismail; Chris Braumann
Journal:  J Gastrointest Surg       Date:  2007-11-20       Impact factor: 3.452

Review 8.  Laparoscopic distal pancreatectomy for adenocarcinoma: safe and reasonable?

Authors:  Lauren M Postlewait; David A Kooby
Journal:  J Gastrointest Oncol       Date:  2015-08

9.  Facilitators and barriers to adopting robotic-assisted surgery: contextualizing the unified theory of acceptance and use of technology.

Authors:  Christine Benmessaoud; Hadi Kharrazi; Karl F MacDorman
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

Review 10.  Telerobotic gastrointestinal surgery: phase 2--safety and efficacy.

Authors:  G H Ballantyne
Journal:  Surg Endosc       Date:  2007-02-08       Impact factor: 3.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.